Detecting early preclinical alzheimer's disease via cognition, neuropsychiatry, and neuroimaging: Qualitative review and recommendations for testing

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S375-S382

  Belleville, Sylvie ^a,b   Fouquet, Céline ^a   Duchesne, Simon ^c,d   Collins, D Louis ^e,f   Hudon, Carol ^c,d  

^a CENTRE DE RECHERCHE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; cognition; early detection of disease; longitudinal studies; mild cognitive impairment; neuroimaging; neuropsychiatry

Indexed keywords

ALZHEIMER DISEASE; ANXIETY DISORDER; APATHY; COGNITION; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE COURSE; EPISODIC MEMORY; EVALUATION STUDY; EXECUTIVE FUNCTION; HUMAN; LANGUAGE ABILITY; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PREDICTION AND FORECASTING; QUALITATIVE RESEARCH; REVIEW; SLEEP DISORDER; TASK PERFORMANCE; COGNITION DISORDERS; COMPLICATION; EARLY DIAGNOSIS; NEUROPSYCHIATRY; PROCEDURES;

ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; NEUROIMAGING; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TESTS;

EID: 84908154879     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141470     Document Type: Review

References (77)

1. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Ster n Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association w orkgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
2. Bruscoli M, Lovestone S (2004) Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 16, 129-140.
3. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. PLoS Med 6, e1000097.
4. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308.
5. Loewenstein DA, Acevedo A, Luis C, Crum T, Barker WW, Duara R (2004) Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without demen tia. J Int Neuropsychol Soc 10, 91-100.
6. Ivanoiu A, Adam S, Van der Linden M, Salmon E, Juillerat AC, Mulligan R, Seron X (2005) Memory evaluation with a newcued recall test in pat ients with mild cognitive impairment and Alzheimer's disease. J Neurol 252, 47-55.
7. Adam S, Van der Linden M, Ivanoiu A, Juillerat AC, Bechet S, Salmon E (2007) Optimization of encodin g specificity for the diagnosis of early AD: The RI-48 task. J Clin Exp Neuropsychol 29, 477-487.
8. Hudon C, Villeneuve S, Belleville S (2011) The effect of semantic orientation at encoding on free-rec all performance in amnestic mild cognitive impairment and probable Alzheimer's disease. J Clin Exp Neuropsychol 33, 631-638.
9. Villeneuve S, Belleville S (2012) The nature of memory failure in mild cognitive impairment: Examining association with neurobiological markers and effect of progression. Neurobiol Aging 33, 1967-1978.
10. Nordahl CW, Ranganath C, Yonelinas AP, DeCarli C, Reed BR, Jagust WJ (2 005) Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia 43, 1688-1697.
11. Hudon C, Belleville S, Gauthier S (2009) The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease. Brain Cogn 70, 17 1-179.
12. Belleville S, Menard MC, Lepage E (2011) Impact of novelty and type of material on recognition in healthy older adults and persons with mild cognitive impairment. Neuropsychologia 49, 2856-28 65.
13. Gagnon LG, Belleville S (2011) Working memory in mild cognitive impairment and Alzheimer's disease: Contribution of forgetting and predictive value of complex span tasks. Neuropsychology 25, 226-236 .
14. Belleville S, ChertkowH, Gauthier S (2007)Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology 21, 458-469.
15. Alescio-Lautier B, Michel BF, Herrera C, Elahmadi A, Chambon C, Touzet C, Paban V (2007) Visual and visuospatial short-term memory in mild cognitive impairment and Alzheimer disease: Role of attention. Neurop sychologia 45, 1948-1960.
16. Belleville S, Rouleau N, Van der Linden M (2006) Use of the Hayling task to measure inhibition of prepotent responses in normal aging and Alzheimer's disease. Brain Cog n 62, 113-119.
17. Belanger S, Belleville S (2009) Semantic inhibition impairment in mild cognitive impairment: A distinctive feature of upcoming cognitive decline? Neuropsychology 23, 592-606.
18. Bé langer S, Belleville S, Gauthier S (2010) Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: Effect of congruency proportion in a Stroop task. Neuropsychologia 48 , 581-590.
19. Rainville C, Lepage E, Gauthier S, Kergoat MJ, Belleville S (2012) Executive function deficits in persons with mild cognitive impairment: A study with a Tower of London task. J Clin Ex p Neuropsychol 34, 306-324.
20. Wylie SA, Ridderinkhof KR, Eckerle MK, Manning CA (2007) Inefficient response inhibition in individuals with mild cognitive impairment. Neuropsychologia 45, 1408-1419.
21. Dannhauser TM, Walker Z, Stevens T, Lee L, Seal M, Shergill SS (2005) The functional anatomy of divided attention in amnestic mild cognitive impairment. Brain 128, 1418-1427.
22. Belleville S, Bherer L, Lepage E, Chertkow H, Gauthier S (2008) Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychologia 46, 2225-2233.
23. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH (2008) Combining early markers strongly predicts conversion from mi ld cognitive impairment to Alzheimer's disease. Biol Psychiatry 64, 871-879.
24. Lehrner J, Gufler R, Guttmann G, Maly J, Gleiss A, Auff E, Dal-Bianco P (2005) Annual conversion to A lzheimer disease among patients with memory complaints attending an outpatient memory clinic: The influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing. Wiener Klinische Wochenschrift 117, 629-635.
25. Peters F, Villeneuve S, Belleville S (2014) Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimagi ng predictors. J Alzheimers Dis 38, 307-318.
26. Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M,Volteau M, Touchon J,VernyM, Dubois B ( 2007) Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study.[Erratum appears in Neurology 70(21) (2008); 2016]. Neurology 69, 1859-1867.
27. Hanninen T, Hallikainen M, Ko ivisto K, Helkala EL, Reinikainen KJ, Soininen H, Mykkanen L, Laakso M, Pyorala K, Riekkinen PJ Sr (1995) A follow-up study of age-Associated memory impairment: Neuropsychological predictors of dementia. J Am Geri atr Soc 43, 1007-1015.
28. Rabin LA, Pare N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA, Santulli RB (2009) Differential memory test sensitivity for diagnosing amnestic mild cognitive im pairment and predicting conversion to Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 16, 357-376.
29. Eckerstrom C, Olsson E, Bjerke M, Malmgren H, Edman A, Wallin A, No rdlund A (2013) A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia. J Alzheimers Dis 36, 421-431.
30. TierneyMC, Sz alai JP, SnowWG, Fisher RH, Nores A, Nadon G, Dunn E, St George-Hyslop PH (1996) Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 46, 661-665.
31. Galton CJ, Erzinclioglu S, Sahakian BJ, Antoun N, Hodges JR (2005) A comparison of the Addenbrooke's Cognitive Examination (ACE), conventional neuropsychological assessment, and simple MRI-based medial t emporal lobe evaluation in the early diagnosis of Alzheimer's disease. Cogn Behav Neurol 18, 144-150.
32. Guarch J, Marcos T, Salamero M, Gasto C, Blesa R (2008) Mild cognitive impairment:Ar isk indicator of later dementia, or a preclinical phase of the disease? Int J Geriatr Psychiatry 23, 257-265.
33. Didic M,Felician O,Barbeau EJ,Mancini J,Latger-Florence C,Tramoni E,Cec caldi M 2013 Impaired visual recognition memory predicts Alzheimer's disease in amnestic mild cognitive impairment Dement Geriatr Cogn Disord 35, 291-299.
34. Griffith HR, Netson KL, Harrell LE, ZamriniEY, Brockington JC, Marson DC (2006) Amnestic mild cognitive impairment: Diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 12, 166-175.
35. Espinosa A, Alegret M, Valero S, Vinyes-Junque G, Hernandez I, Mauleon A, Rosende-Roca M, Ruiz A, Lopez O, Tarraga L, Boada M (2013) A longitudinal follow-up of 550 mild cognitive impairment patients: Evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis 34, 769-780.
36. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr., Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B,Weiner M, Hampel H, North American Alzheimer's Disease Neuroimaging I (2012) Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based u pon biomarkers and neuropsychological test performance. Neurobiol Aging 33, 1203-1214.
37. Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 7, 631-639.
38. Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR (2004) Detecting dementia: Novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 17, 42-48.
39. Ye BS, Seo SW, Lee Y, Kim SY, Choi SH, Lee YM, Kim do H, Han HJ, Na DL, Kim EJ (2012) Neuropsychological performance and conversion to Alzheimer's disease in early-compared to late-onset amnestic mild cognitive impairment: CREDOS study. Dement Geriatr Cogn Disord 34, 156-166.
40. Gallagher D, Mhaolain AN, Coen R, Walsh C, Kilroy D, Belinski K, Bruce I, Coakley D, Walsh JB, Cunningham C, Lawlor BA (2010) Detecting prodromal Alzheimer's disease in mild cognitive impairment: Utility of the CAMCOG and other neuropsychological predictors. Int J Geriatr Psychiatry 25, 1280-1287.
41. Chopard G, Vanholsbeeck G, Tio G, Pitard A, Binetruy M, Rumbach L, Galmiche J (2009) Rapid screening of cognitive change in patients with questionable dementia using the memory impairment screen and the Isaacs set test. J Am Ger iatr Soc 57, 703-708.
42. Belleville S, Gauthier S, Lepage E, Kergoat MJ, Gilbert B (2014) Predicting decline in mild cognitive impairment: A prospective cognitive study. Neuropsychology 28, 643-652.
43. Artero S, Tierney MC, Touchon J, RitchieK(2003) Prediction of transition from cognitive impairment to senile dementia: A prospective, longitudinal study. Acta Psychiatr Scand 107, 390-393.
44. Derby CA, Burns LC, Wang C, Katz MJ, Zimmerman ME, L'Italien G, Guo Z, Berman RM, Lipton RB (2013) Screening for predementia AD: Time-dependent operating characteristics of episod ic memory tests. Neurology 80, 1307-1314.
45. Jessen F, Wiese B, Bickel H, Eifflander-Gorfer S, Fuchs A, Kaduszkiewicz H, Kohler M, Luck T, Mosch E, Pentzek M, Riedel-Heller S G, Wagner M, Weyerer S, Maier W, van den Bussche H, AgeCoDe Study G (2011) Prediction of dementia in primary care patients. PLoS One 6, e16852.
46. Jungwirth S, Zehetmayer S, Bauer P ,Weissgram S, Tragl KH, Fischer P (2009) Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm 116, 1513-1521.
47. Hohman TJ, Beason-Held LL, Lamar M, Resnick SM (2011) Subjective cognitive complaints and longitudinal changes in memory and brain function. Neuropsychology 25, 125-130.
48. Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mosch E, Kaduszkiewicz H, Pentzek M, Riedel-Heller SG, Luck T, Fuchs A, Weyerer S, Werle J, van den Bussche H, Scherer M, MaierW,Wagner M, German Study on Aging C, Dementia in Primary Care P (2014) AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement 10, 76-83.
49. Langlois AS, Belleville S (2014) Subjective cognitive complaint in healthy older adults: Identification of major domains and relation to objective performance. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 21, 257-282.
50. Clé ment F, Belleville S, Gauthier S (2008) Cognitive complaint in mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 14, 222-232.
51. Houde M, Bergman H, Whitehead V, Chertkow H (2008) A predictive depression pattern in mild cognitive impairment. Int J Geriatr Psychiatry 23, 1028-1033.
52. Teng E, Lu PH, Cummings JL (2007) Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geri atr Cogn Disord 24, 253-259.
53. Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, SpallettaG(2010) Neuropsychiatric predictors of progression from amnestic-Mild cognitive impairment to alzheimer's disease: The role of dep ression and apathy. J Alzheimers Dis 20, 175-183.
54. Lobo A,Lopez-Anton R de-la-Camara C Quintanilla MA Campayo A Saz P Workgroup Z 2008 Non-cognitive psychopathological symptoms associated wit h incident mild cognitive impairment and dementia, Alzheimer's type Neurotox Res 14, 263-272.
55. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
56. Jack CR Jr., Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kokmen E, Petersen RC (2002) Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58, 750-757.
57. Jack CR Jr., Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tanga los EG, Kokmen E (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484-489.
58. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63, 693-699.
59. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soininen H (2004) Hippocampus and entorhinal cortex in mild c ognitive impairment and early AD. Neurobiol Aging 25, 303-310.
60. Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR, Aisen PS, Thal LJ (2008) Volumetric M RI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70, 191-199.
61. Stewart R, Dufouil C, Godin O, Ritchie K, Maillard P, Delcroix N, Crivello F, Mazoy er B, Tzourio C (2008) Neuroimaging correlates of subjective memory deficits in a community population. Neurology 70, 1601-1607.
62. Stewart R, Godin O, Crivello F, Maillard P, Mazoyer B , Tzourio C, DufouilC(2011) Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study. Br J Psychiatry 198, 199-205.
63. DeCarli C, Frisoni GB, Clark C M, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR Jr., Scheltens P, Alzheimer's Disease Cooperative Study G (2007) Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cog nitive impairment to dementia. Arch Neurol 64, 108-115.
64. Risacher SL, Saykin AJ,West JD, Shen L, Firpi HA, McDonald BC (2009) Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6, 347-361.
65. Risacher SL, Shen L,West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR Jr., Weiner MW, Saykin AJ (2010) Longitudina l MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort. Neurobiol Aging 31, 1401-1418.
66. Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr., Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM (2009) Alzheimer's disease neuroimaging i nitiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 45, 645-655.
67. JackCRJr., ShiungMM,Gunter JL, O'Brien PC,Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures wit h clinical disease progression in AD. Neurology 62, 591-600.
68. Querbes O, Aubry F, Pariente J, Lotterie JA, Demonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P (2009) Early diagnosis of Alzheimer's disease using cortical thickness: Impact of cognitive reserve. Brain 132, 2036-2047.
69. Duchesne S, Bocti C, De Sousa K, Frisoni GB, Chertkow H, Collins DL (201 0) Amnestic MCI future clinical status prediction using baseline MRI features. Neurobiol Aging 31, 1606-1617.
70. Fan Y, Batmanghelich N, Clark CM, Davatzikos C (2008) Spatial patterns of brain atrophy inMCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 39, 1731-1743.
71. Peter J, Scheef L, Abdulkadir A, Boecker H, Heneka M,Wagner M, Koppara A, Kloppel S, Jessen F, Alzheimer's Disease Neuroimaging I (2014) Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheimers Dement 10, 99-108.
72. Resnick SM, GoldszalAF,Davatzikos C, Golski S, KrautMA, Metter EJ, Bryan RN, Zonderman AB (2000) One-year age changes in MRI brain volumes in older adults. Cereb Cortex 10, 464-472.
73. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA (2005) Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65, 404-411.
74. Sperling R (2007) Functi onal MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann N Y Acad Sci 1097, 146-155.
75. Clement F, Belleville S (2010) Compensation and disease severity on the memory-related activations in mild cognitive impairment. Biol Psychiatry 68, 894-902.
76. Clement F, Belleville S (2012) Effect of disease severity on neural compensation of item and associative recognition in mild cognitive impairment. J Alzheimers Dis 29, 109-123.
77. Galluzzi S, Frisoni GB (2008) Imaging, subjective complaints, and MCI: 30 years before. J Nutr Health Aging 12, 80S-83S.